Skip to main content
. 2024 Jul 11;15:1276410. doi: 10.3389/fpsyt.2024.1276410

Figure 3.

Figure 3

Meta-analysis of the risk ratios/odd ratios on the RCTs (randomised controlled trials) included in the updated meta-analysis for the effect of pharmacogenomics (PGx)-guided medications versus treatment as usual (TAU) for (A) mean differences in symptom improvement (B) Risk ratio for response (C) remission rates.